Diagnostic Biomarker Candidates Including NT5DC2 for Human Uterine Mesenchymal Tumors

Abstract

Unfortunately, uterine leiomyosarcoma still has a poor prognosis. The National Cancer Institute reported that the median overall survival mOS at stage I to stage IV of leiomyosarcoma was 31 months. Norwegian reports show that mOS of uterine leiomyosarcoma is as poor as eight years at stage I, four years at stage II, two years at stage III, and one year at stage IV. Preoperative diagnosis of uterine leiomyosarcoma is difficult in clinical practice. Treated as uterine leiomyoma , however, tumors are often differentially diagnosed from uterine leiomyosarcoma by pathological diagnosis with hysterectomy or myomectomy. Histopathological diagnosis may result in a diagnosis of smooth muscle tumor of unmalignant potential STUMP , and leiomyoma with bizarre nuclei that cannot be declared as malignant or benign. In about half of stage I patients, uterine leiomyosarcoma recurs. However, at present, no anticancer drug that has been shown to be effective in preventing postoperative recurrence has not been established. For this reason, we monitor patients without postoperative treatment, and start clinical treatment when recurrence is confirmed. Uterine leiomyomas, which occur in about 70 of women aged 40 and over in Japan and overseas, are benign tumors, but are extremely difficult to distinguish from uterine leiomyosarcoma. Although progress in diagnostic imaging such as Magnetic Resonance Imaging MRI and Positron Emission Tomography Computed Tomography PET CT is remarkable, uterine leiomyosarcoma is difficult to distinguish from other uterine mesenchymal tumors. No differential biomarker has been identified for uterine other uterine mesenchymal tumors and uterine leiomyosarcoma in surgical pathological diagnosis or clinical examination. This review describes the current diagnosis and treatment for uterine sarcoma, including new trends in the search for biomarker candidates for uterine leiomyosarcoma. Takuma Hayashi | Kenji Sano | Tomoyuki Ichimura | Susumu Tonegawa | Nobuo Yaegashi | Ikuo Konishi "Diagnostic Biomarker Candidates Including NT5DC2 for Human Uterine Mesenchymal Tumors" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-3 , April 2021, URL: https://www.ijtsrd.com/papers/ijtsrd38686.pdf Paper URL: https://www.ijtsrd.com/medicine/other/38686/diagnostic-biomarker-candidates-including-nt5dc2-for-human-uterine-mesenchymal-tumors/takuma-hayashi

Authors and Affiliations

Takuma Hayashi | Kenji Sano | Tomoyuki Ichimura | Susumu Tonegawa | Nobuo Yaegashi | Ikuo Konishi

Keywords

Related Articles

Anatomical Exploration of “Makarasana”

The word Yoga comes from the Sanskrit word Yuj meaning to yoke, join or unite. It implies joining or integrating all aspects of the individual body with mind, and mind with soul to achieve a balanced and healthy life.Yog...

Comprehensive Approach towards M Shopper’s Shopping Behaviour using Shopping Apps – TAM Model Analysis

In current digital era, the mode of retail business is undergoing rapid change. Retailers are shifting their businesses from brick and mortar to e commerce especially m commerce i.e., business transactions via mobile pho...

Gender Inequalities in the Context of Basic Education A Literature Review

Gender inequality in education has been a buzzword in our educational system in recent decades. This paper identifies the factor that creates gender inequality in education and in the world in general. Our study focuses...

Consciousness: Role of Socio-Religious Reformative Movements in Kashmir (1846-1952)

Freedom is one of the basic need without which a living organism cannot develop properly. Human beings, plants and animals all struggle for freedom if kept under restrictions in any way, because it is in their nature to...

Natural Resources in Unconventional Energy Production Capacity on the Basis of the Study A Case Study of Mirzachul Region

The Republic of Uzbekistan achieved its independence, when radical reform in the field of rational nature use all the fields in the array also is to occur. Prospect currently in the country, that is, protection of the en...

Download PDF file
  • EP ID EP695169
  • DOI -
  • Views 71
  • Downloads 0

How To Cite

Takuma Hayashi, Kenji Sano, Tomoyuki Ichimura, Susumu Tonegawa, Nobuo Yaegashi (2021). Diagnostic Biomarker Candidates Including NT5DC2 for Human Uterine Mesenchymal Tumors. International Journal of Trend in Scientific Research and Development, 5(3), -. https://europub.co.uk/articles/-A-695169